Black Diamond Therapeutics (BDTX) Other financing activities (2019 - 2025)
Black Diamond Therapeutics' (BDTX) quarterly Other financing activities came in at $32000.0 in Q1 2025, down 78.67% YoY from $150000.0 in Q1 2024, and down 89.0% on a QoQ basis from $291000.0 in Q4 2024.
Black Diamond Therapeutics (BDTX) Other financing activities (2019 - 2025) Analysis & Trends
Black Diamond Therapeutics (BDTX) has 7 years of Other financing activities data on file, last reported at $32000.0 in Q1 2025.
- Quarterly Other financing activities fell 78.67% year-over-year to $32000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $935000.0 (up 416.57% YoY) and the FY2024 annual result came in at $1.1 million, up 1184.15% from the prior year.
- Other financing activities declined to $32000.0 in Q1 2025, from $291000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $481000.0 in Q1 2021 to a low of -$46000.0 in Q4 2023.
- A 5-year average of $148071.4 and a median of $113500.0 in 2023 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 2906.25% in 2021, down 99.91% in 2021.
- Tracing BDTX's Other financing activities over 5 years: stood at $64000.0 in 2021, then tumbled by 143.75% to -$28000.0 in 2022, then sank by 64.29% to -$46000.0 in 2023, then jumped by 732.61% to $291000.0 in 2024, then slumped by 89.0% to $32000.0 in 2025.
- The last three Other financing activities figures came in at $32000.0 (Q1 2025), $291000.0 (Q4 2024), and $248000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Black Diamond Therapeutics | 125.92 Mn | 15.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 32,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | 291,000.00 |
| Dec 31, 2024 | 291,000.00 |
| Sep 30, 2024 | 248,000.00 |
| Sep 30, 2024 | 248,000.00 |
| Jun 30, 2024 | 364,000.00 |
| Jun 30, 2024 | 364,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Dec 31, 2023 | -46,000.00 |
| Dec 31, 2023 | -46,000.00 |
| Sep 30, 2023 | 77,000.00 |
| Sep 30, 2023 | 77,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | -28,000.00 |
| Dec 31, 2022 | -28,000.00 |
| Sep 30, 2022 | 52,000.00 |
| Sep 30, 2022 | 52,000.00 |